IL15 and leukemia: Large amounts of interleukin-15 (IL-15) released from normal myeloid progenitors [40] promote leukemia control after allo-HSCT by boosting T cell alloreactivity against leukemia cells, enhancing NK expansion and instructing the generation of new memory stem T cells from naïve precursors [41,42,43].